Ayman Al Hendy
Sheikh Shakbhout Medical City · University of Chicago · University of Illinois Chicago
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ayman Al Hendy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07647198 · FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid RecurrenceSheikh Shakhbout Medical City · recruiting · Uterine Fibroids (Leiomyoma) · principal investigator
- Ph1NCT04177693 · Pharmacokinetics and Hepatic Safety of EGCGYale University · completed · Uterine Fibroids · principal investigator
- N/ANCT02696889 · Rejuvenation of Premature Ovarian Failure With Stem CellsUniversity of Illinois Chicago · completed · Primary Ovarian Insufficiency, Low Ovarian Reserve, Premature Ovarian Failure · principal investigator
- Ph2NCT01311869 · Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine FibroidsMeharry Medical College · terminated · Leiomyoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroidsR01HD100367 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · fiscal years 2019 to 2023 · $311,640 awarded in 2023Same name and institution; not confirmed by an ID
- Investigating the effectiveness of COVID-19 testing choices, community engagement, and culturally-embedded mHealth literacy delivery in a medically-underserved, community-based sampleR01ES028615 · NIEHS · UNIVERSITY OF CHICAGO · fiscal years 2017 to 2022 · $475,882 awarded in 2022Same name and institution; not confirmed by an ID
- CENTER FOR WOMEN'S HEALTH RESEARCH FACULTY RECRUITMENTG12RR003032 · NCRR · MEHARRY MEDICAL COLLEGE · fiscal years 2008 to 2010 · $464,103 awarded in 2010Same name and institution; not confirmed by an ID
- EFFECT OF ORAL CONTRACEPTIVES AND ENDGENOUS SEX STEROIDS ON UTERINE LEIOMYOMASP20RR011792 · NCRR · MEHARRY MEDICAL COLLEGE · fiscal years 2008 to 2009 · $14,440 awarded in 2009Same name and institution; not confirmed by an ID
- Meharry Clinical and Translational Research Center (MeTRC)U54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · fiscal years 2009 · $391,120 awarded in 2009Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4R01HD100369 · NICHD · YALE UNIVERSITY · PI Hugh Smith Taylor, HEPING ZHANG · fiscal years 2019 to 2023Named on NCT04177693
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:39 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed